Phio Pharmaceuticals Corp. has completed a private placement offering under Rule 506(b), which includes both securities and warrants. The offering involves a total sales commission of $138,870, managed by H.C. Wainwright & Co., LLC as the broker-dealer.The offering structure combines direct securities issuance with warrant provisions for accredited investors and the placement agent. The company has confirmed that the offering is not intended to last more than one year and is not connected to any business combination transaction. The total offering amount reflects the aggregate purchase price received plus the exercise price for all warrants, assuming cash exercise.

Phio Pharmaceuticals Corp. has completed a private placement offering under Rule 506(b), which includes both securities and warrants. The offering involves a total sales commission of $138,870, managed by H.C. Wainwright & Co., LLC as the broker-dealer.The offering structure combines direct securities issuance with warrant provisions for accredited investors and the placement agent. The company has confirmed that the offering is not intended to last more than one year and is not connected to any business combination transaction. The total offering amount reflects the aggregate purchase price received plus the exercise price for all warrants, assuming cash exercise.